Skip to content

Single versus Double Plastic Stents for Bile Duct Drainage During ERCP: A Clinical Study

Prospective Comparative Study of Single vs Double Plastic Stents for Biliary Drainage in Patients of Malignant Distal CBD Obstruction Undergoing ERCP - NIL

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/099651
Enrollment
200
Registered
2025-12-22
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K831- Obstruction of bile duct

Interventions

Intervention1: Plastic stent: Arm A (Double DPT): ERCP with placement of two DPT stents (both 7Fr or 10Fr, as per anatomy) Control Intervention1: Plastic stent: Arm B (Single DPT) ERCP with placement

Sponsors

Dr Hemanta Kumar Nayak
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age 18 to 80 years. 2.Indicated for biliary drainage by ERCP (malignant obstruction. 3.CBD diameter greater than 8 mm. 4.Distal CBD or mid-distal CBD block. 5.Written informed consent.

Exclusion criteria

Exclusion criteria: 1.Previous biliary stenting. 2.Coagulopathy (INR greater than 1.5 or platelets less than 50,000). 3.Severe comorbidities (e.g., advanced cardiac or renal disease). 4.Pregnancy. 5.Altered anatomy preventing standard ERCP.

Design outcomes

Primary

MeasureTime frame
The Resolution of cholestasis that is greater than equal to 50% reduction in bilirubin at 7 days or normalization within 4 weeks and improvement in symptoms.Timepoint: At Day 7 and Day 28

Secondary

MeasureTime frame
1.Stent dysfunction rate at 3 months 2.Need for re-intervention 3.Procedure-related complications (bleeding, perforation, pancreatitis, infection) 4.Stent migration or occlusion 5.Patency duration (time to dysfunction) Timepoint: At 3 months and 6 months

Countries

India

Contacts

Public ContactDr Hemanta Kumar Nayak

AIIMS, Bhubaneswar

drhemantnayak@gmail.com7008927243

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026